Literature DB >> 29966930

Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder.

Jasper O Nuninga1, Thomas F I Claessens2, Metten Somers2, René Mandl2, Wendy Nieuwdorp2, Marco P Boks2, Steven Bakker2, Marieke J H Begemann2, Sophie Heringa2, Iris E C Sommer3.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) is the most effective treatment for patients suffering from major depression. However, its use is limited due to concerns about negative effects on cognition. Unilateral ECT is associated with transient cognitive side-effects, while case-controlled studies investigating the effect of bilateral ECT on cognition remain scarce. We investigate the effects of bilateral ECT on cognition in depression in a longitudinal case-controlled study. We hypothesize that adverse cognitive effects of bilateral ECT are transient rather than long-term.
METHODS: A total of 48 depressed patients and 19 controls were included in the study and assessed with a battery of cognitive tests, including tests of: working memory, verbal fluency, visuospatial abilities, verbal/visual memory and learning, processing speed, inhibition, attention and task-switching, and premorbid IQ. Patients underwent three cognitive assessments: at baseline (n = 43), after ten ECT sessions (post-treatment; n = 39) and six months after the tenth ECT session (follow-up; n = 25). Healthy controls underwent the same cognitive assessment at baseline and after five-weeks.
RESULTS: Within the patient group, transient adverse cognitive side-effects were observed for verbal memory and learning, and verbal fluency. None of the cognitive domains tested in this study showed persisting impairments. LIMITATIONS: A relatively high attrition rate is observed and autobiographical memory was not assessed.
CONCLUSION: This study shows that bilateral ECT has negative cognitive effects on short-term. These effects could be explained by a decrease in cognitive performance, a lack of learning effects or a combination. However, the decrease in cognitive functioning appears to recover after six months.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2018        PMID: 29966930     DOI: 10.1016/j.jad.2018.06.040

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder.

Authors:  Haihua Tian; Guangxue Li; Guoan Xu; Jimeng Liu; Xiaohan Wan; Jiao Zhang; Shuguang Xie; Jia Cheng; Shugui Gao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-02       Impact factor: 5.270

2.  Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trial

Authors:  Victor M. Tang; Daniel M. Blumberger; Julia Dimitrova; Alanah Throop; Shawn M. McClintock; Daphne Voineskos; Jonathan Downar; Yuliya Knyahnytska; Benoit H. Mulsant; Paul B. Fitzgerald; Zafiris J. Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

3.  Volume increase in the dentate gyrus after electroconvulsive therapy in depressed patients as measured with 7T.

Authors:  Jasper O Nuninga; René C W Mandl; Marco P Boks; Steven Bakker; Metten Somers; Sophie M Heringa; Wendy Nieuwdorp; Hans Hoogduin; René S Kahn; Peter Luijten; Iris E C Sommer
Journal:  Mol Psychiatry       Date:  2019-03-12       Impact factor: 15.992

4.  Improved Safety of Hybrid Electroconvulsive Therapy Compared With Standard Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Randomized, Double-Blind, Parallel-Group Pilot Trial.

Authors:  Jing-Ya Zhang; Shu-Xian Xu; Lun Zeng; Li-Chang Chen; Jia Li; Zhao-Yun Jiang; Bai-Jian Tan; Chen-Long Gu; Wen-Tao Lai; Xiao-Ming Kong; Jian Wang; Han Rong; Xin-Hui Xie
Journal:  Front Psychiatry       Date:  2022-05-23       Impact factor: 5.435

5.  The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.

Authors:  Sanne J H van Rooij; Patricio Riva-Posse; William M McDonald
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-03

Review 6.  Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder.

Authors:  Xiuli Wang; Bochao Cheng; Neil Roberts; Song Wang; Ya Luo; Fangfang Tian; Suping Yue
Journal:  Hum Brain Mapp       Date:  2021-08-25       Impact factor: 5.038

Review 7.  Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism.

Authors:  Ming Li; Xiaoxiao Yao; Lihua Sun; Lihong Zhao; Wenbo Xu; Haisheng Zhao; Fangyi Zhao; Xiaohan Zou; Ziqian Cheng; Bingjin Li; Wei Yang; Ranji Cui
Journal:  Front Psychol       Date:  2020-02-20

8.  Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.

Authors:  Ian M Anderson; R Hamish McAllister-Williams; Darragh Downey; Rebecca Elliott; Colleen Loo
Journal:  Psychol Med       Date:  2020-02-27       Impact factor: 7.723

9.  Cognitive Considerations in Major Depression: Evaluating the Effects of Pharmacotherapy and ECT on Mood and Executive Control Deficits.

Authors:  Alfredo Spagna; Jason Wang; Isabella Elaine Rosario; Li Zhang; Meidan Zu; Kai Wang; Yanghua Tian
Journal:  Brain Sci       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.